Current and future strategies for the diagnosis and treatment of the alpha-gal syndrome (AGS)

R Vaz-Rodrigues, L Mazuecos… - Journal of asthma and …, 2022 - Taylor & Francis
The α-Gal syndrome (AGS) is a pathognomonic immunoglobulin E (IgE)-mediated delayed
anaphylaxis in foods containing the oligosaccharide galactose-α-1, 3-galactose (α-Gal) such …
被引用次数：29 相关文章

Current and Future Strategies for the Diagnosis and Treatment of the Alpha-Gal Syndrome (AGS)

R Vaz-Rodrigues, L Mazuecos… - Journal of asthma …, 2022 - pubmed.ncbi.nlm.nih.gov
The α-Gal syndrome (AGS) is a pathognomonic immunoglobulin E (IgE)-mediated delayed
anaphylaxis in foods containing the oligosaccharide galactose-α-1, 3-galactose (α-Gal) such …
[PDF] scienceopen.com

[PDF][PDF] Current and Future Strategies for the Diagnosis and Treatment of the Alpha-Gal Syndrome (AGS)

R Vaz-Rodrigues, L Mazuecos… - Journal of Asthma and …, 2022 - scienceopen.com
The α-Gal syndrome (AGS) is a pathognomonic immunoglobulin E (IgE)-mediated delayed
anaphylaxis in foods containing the oligosaccharide galactose-α-1, 3-galactose (α-Gal) such …

Current and Future Strategies for the Diagnosis and Treatment of the Alpha-Gal Syndrome (AGS)

R Vaz-Rodrigues, L Mazuecos… - Journal of Asthma and …, 2022 - dovepress.com
The α-Gal syndrome (AGS) is a pathognomonic immunoglobulin E (IgE)-mediated delayed
anaphylaxis in foods containing the oligosaccharide galactose-α-1, 3-galactose (α-Gal) such …

Current and future strategies for the diagnosis and treatment of the Alpha-Gal Syndrome (AGS)

R Vaz Rodrigues, L Mazuecos - 2022 - digital.csic.es
The α-Gal syndrome (AGS) is a pathognomonic immunoglobulin E (IgE)-mediated delayed
anaphylaxis in foods containing the oligosaccharide galactose-α-1, 3-galactose (α-Gal) such …

Current and Future Strategies for the Diagnosis and Treatment of the Alpha-Gal Syndrome (AGS)

R Vaz-Rodrigues, L Mazuecos… - Journal of Asthma and …, 2022 - search.proquest.com
The α-Gal syndrome (AGS) is a pathognomonic immunoglobulin E (IgE)-mediated delayed
anaphylaxis in foods containing the oligosaccharide galactose-α-1, 3-galactose (α-Gal) such …

Current and Future Strategies for the Diagnosis and Treatment of the Alpha-Gal Syndrome (AGS).

R Vaz-Rodrigues, L Mazuecos… - Journal of Asthma and …, 2022 - europepmc.org
The α-Gal syndrome (AGS) is a pathognomonic immunoglobulin E (IgE)-mediated delayed
anaphylaxis in foods containing the oligosaccharide galactose-α-1, 3-galactose (α-Gal) such …

Current and future strategies for the diagnosis and treatment of the Alpha-Gal Syndrome (AGS)

R Vaz Rodrigues, L Mazuecos - 2022 - lareferencia.info
The α-Gal syndrome (AGS) is a pathognomonic immunoglobulin E (IgE)-mediated delayed
anaphylaxis in foods containing the oligosaccharide galactose-α-1, 3-galactose (α-Gal) such …
[HTML] nih.gov

[HTML][HTML] Current and Future Strategies for the Diagnosis and Treatment of the Alpha-Gal Syndrome (AGS)

R Vaz-Rodrigues, L Mazuecos… - Journal of Asthma and …, 2022 - ncbi.nlm.nih.gov
The α-Gal syndrome (AGS) is a pathognomonic immunoglobulin E (IgE)-mediated delayed
anaphylaxis in foods containing the oligosaccharide galactose-α-1, 3-galactose (α-Gal) such …
[PDF] researchgate.net

[PDF][PDF] Current and Future Strategies for the Diagnosis and Treatment of the Alpha-Gal Syndrome (AGS)

R Vaz-Rodrigues, L Mazuecos… - Journal of Asthma and …, 2022 - researchgate.net
The α-Gal syndrome (AGS) is a pathognomonic immunoglobulin E (IgE)-mediated delayed
anaphylaxis in foods containing the oligosaccharide galactose-α-1, 3-galactose (α-Gal) such …